BioSig Technologies Inc.

NASDAQ: BSGM · Real-Time Price · USD
5.07
-0.03 (-0.59%)
At close: Aug 15, 2025, 3:08 PM

BioSig Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
40K 18K 286K 441K
Cost of Revenue
n/a n/a 57K 199K
Gross Profit
40K 18K 229K 242K
Operating Income
-12.86M -28.51M -27.27M -33.41M
Interest Income
n/a 9K 3K 2K
Pretax Income
-10.34M -28.69M -27.26M -32.86M
Net Income
-10.33M -29.04M -27.27M -31.36M
Selling & General & Admin
11.63M 23.08M 21.38M 27.85M
Research & Development
832K 5.09M 5.82M 5.6M
Other Expenses
441K 361K 293K 198K
Operating Expenses
12.9M 28.53M 27.49M 33.65M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
12.9M 28.53M 27.55M 33.85M
Income Tax Expense
174K n/a 9K -1.49M
Shares Outstanding (Basic)
140.42M 73.52M 43.07M 33.51M
Shares Outstanding (Diluted)
140.42M 73.52M 43.07M 33.51M
EPS (Basic)
-0.07 -0.4 -0.63 -0.94
EPS (Diluted)
-0.07 -0.4 -0.63 -0.94
EBITDA
-12.42M -28.15M -26.97M -33.21M
EBIT
-12.61M -28.51M -27.27M -33.41M
Depreciation & Amortization
188K 361K 666K 639K